XTX Topco Ltd Takes Position in Inspire Medical Systems, Inc. (NYSE:INSP)

XTX Topco Ltd acquired a new position in Inspire Medical Systems, Inc. (NYSE:INSP) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 2,478 shares of the company’s stock, valued at approximately $459,000.

A number of other institutional investors have also recently bought and sold shares of the business. Smartleaf Asset Management LLC lifted its position in shares of Inspire Medical Systems by 178.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 357 shares of the company’s stock worth $66,000 after purchasing an additional 229 shares in the last quarter. Merit Financial Group LLC acquired a new position in Inspire Medical Systems in the 4th quarter valued at approximately $313,000. Jennison Associates LLC acquired a new position in Inspire Medical Systems in the 4th quarter valued at approximately $8,821,000. Janney Montgomery Scott LLC lifted its position in Inspire Medical Systems by 248.5% in the 4th quarter. Janney Montgomery Scott LLC now owns 4,806 shares of the company’s stock worth $891,000 after buying an additional 3,427 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. acquired a new stake in shares of Inspire Medical Systems during the 4th quarter valued at $292,000. 94.91% of the stock is currently owned by institutional investors and hedge funds.

Inspire Medical Systems Stock Performance

Shares of NYSE:INSP opened at $150.42 on Monday. The company’s fifty day moving average is $166.16 and its 200-day moving average is $183.05. Inspire Medical Systems, Inc. has a 52 week low of $123.00 and a 52 week high of $257.40. The company has a market capitalization of $4.48 billion, a PE ratio of 86.95, a P/E/G ratio of 2.86 and a beta of 1.39.

Inspire Medical Systems (NYSE:INSP) last released its quarterly earnings results on Monday, February 10th. The company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.74 by $0.41. Inspire Medical Systems had a return on equity of 8.19% and a net margin of 6.67%. On average, analysts forecast that Inspire Medical Systems, Inc. will post 2.16 EPS for the current year.

Insider Transactions at Inspire Medical Systems

In other Inspire Medical Systems news, insider Randy Ban sold 25,584 shares of the firm’s stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $183.50, for a total value of $4,694,664.00. Following the transaction, the insider now directly owns 7,259 shares of the company’s stock, valued at approximately $1,332,026.50. This trade represents a 77.90 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CTO John Rondoni sold 583 shares of the firm’s stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $170.49, for a total value of $99,395.67. Following the completion of the transaction, the chief technology officer now owns 10,424 shares in the company, valued at $1,777,187.76. This represents a 5.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.10% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on INSP shares. Wells Fargo & Company cut their price objective on Inspire Medical Systems from $198.00 to $195.00 and set an “equal weight” rating for the company in a report on Tuesday, February 11th. KeyCorp reaffirmed an “overweight” rating and set a $234.00 price target (down from $236.00) on shares of Inspire Medical Systems in a research note on Friday, January 24th. Robert W. Baird lowered their price target on Inspire Medical Systems from $252.00 to $248.00 and set an “outperform” rating for the company in a research note on Tuesday, February 11th. Piper Sandler cut their price objective on shares of Inspire Medical Systems from $260.00 to $233.00 and set an “overweight” rating on the stock in a research report on Monday, February 10th. Finally, Royal Bank of Canada decreased their target price on shares of Inspire Medical Systems from $260.00 to $215.00 and set an “outperform” rating for the company in a research report on Tuesday, April 15th. Three analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $222.20.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.